The Impact of Metformin on Cardiac Troponin-I and ST Resolution in Patients with ST Elevation Myocardial Infarction Undergoing Thrombolytic Therapy
Background: Thrombolytic therapy is a key in the management of ST elevated myocardial infarction (STEMI). Metformin implies a series of cardioprotective effects. We aimed to investigate how pretreatment with metformin could affect cardiac troponin I (cTnI) levels following reteplase therapy amid STE...
Saved in:
Main Authors: | Naser Aslanabadi (Author), Samineh Beheshtirouy (Author), Sina Mashayekhi (Author), Zahra Heidari (Author), Sana Hamedani (Author), Taher Entezari-Maleki (Author) |
---|---|
Format: | Book |
Published: |
Tabriz University of Medical Sciences,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effects of Allopurinol on Levels of Cardiac Troponin Following Non-ST Elevation Myocardial Infarction: A Pilot Randomized Clinical Trial
by: Sajad Khiali, et al.
Published: (2021) -
Vitamin D is a predictor of ST segment resolution and infarct size following thrombolysis in patients with acute ST elevation myocardial infarction
by: Ahmad Separham, et al.
Published: (2017) -
Post Thrombolytic St-Segment Resolution Outcome in Acute Myocardial Infarction Patients
by: Aamir Ahmad, et al.
Published: (2022) -
The pattern and risk factors associated with adverse drug reactions induced by Reteplase in patients with acute ST-elevation myocardial infarction: The first report from Iranian population
by: Naser Aslanabadi, et al.
Published: (2015) -
Troponin I Cutoff for Non-ST-Segment Elevation Myocardial Infarction in Sepsis
by: Meng-Ko Tsai, et al.
Published: (2022)